BioInsights - Preclinical & translational R&D - spotlight

CELL AND GENE THERAPY INSIGHTS

Preclinical & translational R&D

February 2023
Preclinical & translational R&D
Download PDF

Interview

Assessing the evolving AAV preclinical safety landscape in 2023 & beyond

Assessing the evolving AAV preclinical safety landscape in 2023 & beyond

Basel Assaf
4 April
Read
Navigating the path to clinic for ATMPs: a regulator’s perspective

Navigating the path to clinic for ATMPs: a regulator’s perspective

James W McBlane
2 February
Read
Preclinical toolkit evolution for cancer vaccines & CAR-T cell therapy

Preclinical toolkit evolution for cancer vaccines & CAR-T cell therapy

Adam Snook
18 January
Read

Viewpoint

Preclinical safety assessment in therapeutic genome editing

Preclinical safety assessment in therapeutic genome editing

Roberto Nitsch
10 March
Read
Addressing gene therapy translational R&D bottlenecks in the CNS

Addressing gene therapy translational R&D bottlenecks in the CNS

Anindya Sen
9 March
Read
Key considerations when translating a cell therapy product into the clinic

Key considerations when translating a cell therapy product into the clinic

Anthony Ting
6 February
Read